Department of Cardiovascular Medicine, Heart, Vascular, and Thoracic Institute, Cleveland Clinic Foundation, Cleveland, Ohio, USA.
Department of Internal Medicine, Cleveland Clinic Foundation, Cleveland, Ohio, USA.
Open Heart. 2022 Dec;9(2). doi: 10.1136/openhrt-2022-002108.
Patients undergoing transcatheter aortic valve implantation (TAVI) often have multiple comorbidities, such as anaemia and chronic inflammatory disorders. We sought to investigate the association between preoperative and postoperative haematological parameters and clinical outcomes in TAVI patients at mid-term follow-up.
In the present study, consecutive patients (N=908) who underwent TAVI at the Cleveland Clinic between 2017 and 2019 with available complete blood counts were studied. Data were collected on preoperative and postoperative anaemia and elevations in neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR). Survival analysis was used to study the association of haematologic parameters with all-cause mortality and major adverse cardiac and cerebrovascular events (MACCE).
We found that preoperative anaemia and elevated NLR were significantly associated with a higher risk of all-cause mortality (aHR=1.6 (95% CI: 1.1 to 2.0) and 1.4 (95% CI: 1.1 to 1.6), respectively) and MACCE (aHR=1.9 (95% CI: 1.3 to 2.8) and 1.6 (95% CI: 1.1 to 2.4), respectively). While an elevated preoperative PLR was not associated with increased mortality risk, it had a significant association with MACCE risk (aHR: 1.6 (95% CI: 1.1 to 2.4)). Further, postoperative anaemia, elevated NLR and PLR were associated with increased risks of all-cause mortality and MACCE.
Pathological alterations in haematological parameters were associated with higher risks of post-TAVI mortality and MACCE at mid-term follow-up. Our findings advocate for further incorporating haematological parameters in the preoperative evaluation of TAVI candidates.
接受经导管主动脉瓣置换术(TAVI)的患者通常存在多种合并症,如贫血和慢性炎症性疾病。我们旨在研究 TAVI 患者中期随访时术前和术后血液学参数与临床结局之间的关系。
本研究纳入了 2017 年至 2019 年在克利夫兰诊所接受 TAVI 治疗且有完整全血细胞计数数据的连续患者(N=908)。收集了术前和术后贫血以及中性粒细胞与淋巴细胞比值(NLR)和血小板与淋巴细胞比值(PLR)升高的数据。生存分析用于研究血液学参数与全因死亡率和主要不良心脏和脑血管事件(MACCE)的关系。
我们发现术前贫血和升高的 NLR 与全因死亡率(调整后的 HR [aHR] =1.6 [95%CI:1.1 至 2.0] 和 1.4 [95%CI:1.1 至 1.6])和 MACCE(aHR=1.9 [95%CI:1.3 至 2.8] 和 1.6 [95%CI:1.1 至 2.4])的风险显著相关。而术前升高的 PLR 与死亡率风险增加无关,但与 MACCE 风险显著相关(aHR:1.6 [95%CI:1.1 至 2.4])。此外,术后贫血、升高的 NLR 和 PLR 与全因死亡率和 MACCE 的风险增加相关。
血液学参数的病理改变与 TAVI 后中期死亡率和 MACCE 风险增加相关。我们的研究结果主张在 TAVI 候选者的术前评估中进一步纳入血液学参数。